Diametric Capital, LP - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 233 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
Diametric Capital, LP ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$950,000
+83.8%
18,110
+17.4%
0.73%
+16.1%
Q1 2020$517,000
-36.9%
15,430
-14.6%
0.63%
+4.8%
Q4 2019$819,000
+50.0%
18,073
+26.0%
0.60%
+32.9%
Q3 2019$546,000
-42.8%
14,339
-34.7%
0.45%
-25.7%
Q2 2019$955,00021,9480.61%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Prosight Management, LP 1,210,377$37,134,36611.77%
Gagnon Advisors, LLC 180,331$5,532,5554.63%
GAGNON SECURITIES LLC 565,429$17,347,3614.35%
ARDSLEY ADVISORY PARTNERS LP 310,000$9,510,8002.12%
RICE HALL JAMES & ASSOCIATES, LLC 968,485$29,713,1201.89%
AlphaCentric Advisors LLC 103,000$3,160,0401.79%
1492 Capital Management LLC 79,687$2,444,7971.58%
ARDSLEY ADVISORY PARTNERS LP 149,000$4,571,3201.02%
OUTFITTER FINANCIAL LLC 32,305$991,1170.93%
Rock Springs Capital Management LP 1,055,500$32,382,7400.87%
View complete list of PACIRA PHARMACEUTICALS INC shareholders